세계의 바이러스 벡터 서비스 시장 보고서(2025년)

Viral vector service refers to the activities involved in designing, producing, and validating viral vectors used to deliver genes in both research and therapeutic settings. These services support the safe and efficient transfer of genetic material into target cells for developing advanced biologics and gene therapies. They ensure high-quality vector production by following standardized procedures and adhering to regulatory requirements.

The primary service types within viral vector services include process development, manufacturing, quality control, and others. Process development involves the systematic design, optimization, and scaling of a production or manufacturing process to ensure efficiency, consistency, and compliance with quality standards. These services are applied to a range of vector types, such as adenoviral vectors, lentiviral vectors, adeno-associated viral (AAV) vectors, retroviral vectors, and more. They are utilized in applications such as gene therapy, vaccinology, oncology, and others, and serve end users including pharmaceutical and biotechnology companies, research institutions, and additional stakeholders.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The viral vector service market research report is one of a series of new reports from The Business Research Company that provides viral vector service market statistics, including the viral vector service industry global market size, regional shares, competitors with the viral vector service market share, detailed viral vector service market segments, market trends, and opportunities, and any further data you may need to thrive in the viral vector service industry. This viral vector service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The viral vector service market size has grown exponentially in recent years. It will grow from $2.04 billion in 2024 to $2.53 billion in 2025 at a compound annual growth rate (CAGR) of 24.4%. Growth during the historic period can be linked to increased government funding for biotechnology research, rising investment by pharmaceutical companies in viral vector manufacturing, greater academic collaboration in gene delivery research, expansion of vaccine development efforts using viral vectors, and growing awareness of advanced therapeutic modalities.

The viral vector service market size is expected to see exponential growth in the next few years. It will grow to $5.99 billion in 2029 at a compound annual growth rate (CAGR) of 24.0%. Growth in the forecast period can be attributed to the rising outsourcing of viral vector production to CDMOs, heightened focus on expanding large-scale manufacturing capacity, growing demand for efficient vector supply chains, continued expansion of biopharmaceutical manufacturing infrastructure, and increasing adoption of automation in vector production. Key trends anticipated in the forecast period include innovations in modular bioprocessing systems, advancements in digital twin technologies, the development of continuous manufacturing platforms, progress in process analytical technologies (PAT), and the integration of robotics and AI-driven optimization into viral vector production.

The increasing prevalence of infectious diseases is expected to drive the growth of the viral vector services market in the coming years. Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, and can be transmitted directly or indirectly from one person to another. The incidence of infectious diseases is rising, partly due to increased global travel, which facilitates the rapid spread of pathogens across borders. Viral vector services play a critical role in managing infectious diseases by providing reliable platforms for the development of vaccines and gene-based therapeutics. These services enable the efficient delivery of genetic material to target cells, speeding up the development of effective treatments and improving public health responses. For example, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis (a contagious bacterial infection primarily affecting the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. As such, the growing prevalence of infectious diseases is driving the expansion of the viral vector services market.

Key companies in the viral vector services market are focusing on innovations in lentiviral vector design and manufacturing, such as fourth-generation vector systems. These advanced systems are engineered to enhance payload capacity, potency, and safety, while also streamlining the development of complex gene therapies. Fourth-generation vector systems are designed with improved safety profiles, optimized gene packaging capabilities, and modular components that enable scalable, plug-and-play manufacturing for cell and gene therapies. For instance, in May 2023, Oxford Biomedica plc, a UK-based viral vector contract development and manufacturing organization (CDMO), launched the TetraVecta system. This system improves vector quality, potency, and packaging efficiency, while also incorporating advanced safety features. It facilitates the creation of high-titer, stable producer cell lines, supporting scalable in vivo gene therapy development. TetraVecta helps streamline the manufacturing process, reducing production timelines and improving overall efficiency for gene therapy programs.

In October 2025, Oxford Biomedica plc acquired RTP Operating LLC for $4.5 million (£3.4 million) to expand its viral vector manufacturing capabilities in the United States. This acquisition allows Oxford Biomedica (OXB) to enhance its commercial-scale viral vector manufacturing capacity, boosting its end-to-end contract development and manufacturing organization (CDMO) services. It also increases its good manufacturing practice (GMP) capacity, supporting both clinical and commercial gene therapy programs for existing and new clients. RTP Operating LLC, a U.S.-based biopharmaceutical company, provides a commercial-scale viral vector manufacturing facility.

Major companies operating in the viral vector service market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, FUJIFILM Diosynth Biotechnologies, Danaher Corporation, Sartorius AG, CJ CheilJedang Corp., Charles River Laboratories Inc., Takara Bio Inc., Oxford Biomedica plc, ProBioGen AG, NorthX Biologics Ltd., PackGene Biotech Ltd., Ascend Advanced Therapies Ltd., VectorBuilder Inc., ViroCell Biologics Ltd., Genezen Ltd., Scorpius BioManufacturing Ltd., VGXI Inc., Creative Biogene Ltd., ReiThera Ltd., Tailored Genes Ltd., CoJourney Ltd., InnovaVector Ltd., 3PBIOVIAN Ltd.

North America was the largest region in the viral vector service market in 2024. The regions covered in viral vector service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the viral vector service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral vector service market includes revenues earned by entities through vector design, process development, analytical testing, scale-up production, quality control, regulatory support, purification, and fill and finish. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Vector Service Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral vector service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral vector service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector service market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service Type: Process Development; Manufacturing; Quality Control; Other Service Types
• 2) By Vector Type: Adenoviral Vectors; Lentiviral Vectors; Adeno-Associated Viral Vectors; Retroviral Vectors; Other Vector Types
• 3) By Application: Gene Therapy; Vaccinology; Oncology; Other Applications
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Research Institutes; Other End-Users
• Subsegments:
• 1) By Process Development: Vector Design; Assay Development; Cell Line Development; Process Optimization
• 2) By Manufacturing: Upstream Production; Downstream Purification; Formulation Development; Scale-Up Production
• 3) By Quality Control: Analytical Testing; Safety Testing; Potency Testing; Stability Testing
• Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; Lonza Group AG; FUJIFILM Diosynth Biotechnologies; Danaher Corporation; Sartorius AG; CJ CheilJedang Corp.; Charles River Laboratories Inc.; Takara Bio Inc.; Oxford Biomedica plc; ProBioGen AG; NorthX Biologics Ltd.; PackGene Biotech Ltd.; Ascend Advanced Therapies Ltd.; VectorBuilder Inc.; ViroCell Biologics Ltd.; Genezen Ltd.; Scorpius BioManufacturing Ltd.; VGXI Inc.; Creative Biogene Ltd.; ReiThera Ltd.; Tailored Genes Ltd.; CoJourney Ltd.; InnovaVector Ltd.; 3PBIOVIAN Ltd.
• Countries:

Table of Contents

1. Executive Summary

2. Viral Vector Service Market Characteristics

3. Viral Vector Service Market Trends And Strategies

4. Viral Vector Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viral Vector Service Growth Analysis And Strategic Analysis Framework

• 5.1. Global Viral Vector Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Viral Vector Service Market Growth Rate Analysis
• 5.4. Global Viral Vector Service Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Viral Vector Service Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Viral Vector Service Total Addressable Market (TAM)

6. Viral Vector Service Market Segmentation

• 6.1. Global Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Process Development
• Manufacturing
• Quality Control
• Other Service Types
• 6.2. Global Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adenoviral Vectors
• Lentiviral Vectors
• Adeno-Associated Viral Vectors
• Retroviral Vectors
• Other Vector Types
• 6.3. Global Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Vaccinology
• Oncology
• Other Applications
• 6.4. Global Viral Vector Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Research Institutes
• Other End-Users
• 6.5. Global Viral Vector Service Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vector Design
• Assay Development
• Cell Line Development
• Process Optimization
• 6.6. Global Viral Vector Service Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Upstream Production
• Downstream Purification
• Formulation Development
• Scale-Up Production
• 6.7. Global Viral Vector Service Market, Sub-Segmentation Of Quality Control, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analytical Testing
• Safety Testing
• Potency Testing
• Stability Testing

7. Viral Vector Service Market Regional And Country Analysis

• 7.1. Global Viral Vector Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Viral Vector Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Vector Service Market

• 8.1. Asia-Pacific Viral Vector Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Vector Service Market

• 9.1. China Viral Vector Service Market Overview
• 9.2. China Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Vector Service Market

• 10.1. India Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Vector Service Market

• 11.1. Japan Viral Vector Service Market Overview
• 11.2. Japan Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Vector Service Market

• 12.1. Australia Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Vector Service Market

• 13.1. Indonesia Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Vector Service Market

• 14.1. South Korea Viral Vector Service Market Overview
• 14.2. South Korea Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Vector Service Market

• 15.1. Western Europe Viral Vector Service Market Overview
• 15.2. Western Europe Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Vector Service Market

• 16.1. UK Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Vector Service Market

• 17.1. Germany Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Vector Service Market

• 18.1. France Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Vector Service Market

• 19.1. Italy Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Vector Service Market

• 20.1. Spain Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Vector Service Market

• 21.1. Eastern Europe Viral Vector Service Market Overview
• 21.2. Eastern Europe Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Vector Service Market

• 22.1. Russia Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Vector Service Market

• 23.1. North America Viral Vector Service Market Overview
• 23.2. North America Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Vector Service Market

• 24.1. USA Viral Vector Service Market Overview
• 24.2. USA Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Vector Service Market

• 25.1. Canada Viral Vector Service Market Overview
• 25.2. Canada Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Vector Service Market

• 26.1. South America Viral Vector Service Market Overview
• 26.2. South America Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Vector Service Market

• 27.1. Brazil Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Vector Service Market

• 28.1. Middle East Viral Vector Service Market Overview
• 28.2. Middle East Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Vector Service Market

• 29.1. Africa Viral Vector Service Market Overview
• 29.2. Africa Viral Vector Service Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Viral Vector Service Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Viral Vector Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Vector Service Market Competitive Landscape And Company Profiles

• 30.1. Viral Vector Service Market Competitive Landscape
• 30.2. Viral Vector Service Market Company Profiles
  • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. FUJIFILM Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Viral Vector Service Market Other Major And Innovative Companies

• 31.1. Sartorius AG
• 31.2. CJ CheilJedang Corp.
• 31.3. Charles River Laboratories Inc.
• 31.4. Takara Bio Inc.
• 31.5. Oxford Biomedica plc
• 31.6. ProBioGen AG
• 31.7. NorthX Biologics Ltd.
• 31.8. PackGene Biotech Ltd.
• 31.9. Ascend Advanced Therapies Ltd.
• 31.10. VectorBuilder Inc.
• 31.11. ViroCell Biologics Ltd.
• 31.12. Genezen Ltd.
• 31.13. Scorpius BioManufacturing Ltd.
• 31.14. VGXI Inc.
• 31.15. Creative Biogene Ltd.

32. Global Viral Vector Service Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Vector Service Market

34. Recent Developments In The Viral Vector Service Market

35. Viral Vector Service Market High Potential Countries, Segments and Strategies

• 35.1 Viral Vector Service Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Viral Vector Service Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Viral Vector Service Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer